
Expert hails new malaria drug approval for newborns as turning point for Africa
Switzerland’s recent approval of Coartem Baby, the first antimalarial treatment specifically designed for newborns and very young children, is a major step forward in tackling one of Africa’s most pressing public health challenges, says Dr Fortunate …